Legend Biotech (LEGN) Presents Two-Year Analysis of CARTITUDE-1 Showing Early, Durable and Deepening Responses of Ciltacabtagene Autoleucel (cilta-cel) in Heavily Pretreated Patients with Multiple Mye
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| (NASDAQ: LEGN) | Delayed: 17.88 +0.08 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.80 | 52 Week High | $ | |||
| Open | $17.61 | 52 Week Low | $ | |||
| Day High | $18.28 | P/E | N/A | |||
| Day Low | $17.56 | EPS | $ | |||
| Volume | 2,458,894 | |||||
